Literature DB >> 18415590

[Not Available].

B Bromm1.   

Abstract

Year:  1992        PMID: 18415590     DOI: 10.1007/BF02529692

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  7 in total

1.  The measurement of pain; prototype for the quantitative study of subjective responses.

Authors:  H K BEECHER
Journal:  Pharmacol Rev       Date:  1957-03       Impact factor: 25.468

2.  [Comparison of the action of 2 effective analgesics. Experimental study: tramadol versus tilidine/naloxone].

Authors:  B Bromm; W M Herrmann; E Scharein
Journal:  Fortschr Med       Date:  1989-06-10

3.  [Mechanisms of pain development and pain treatment].

Authors:  M Zimmermann
Journal:  Internist (Berl)       Date:  1986-07       Impact factor: 0.743

4.  Imipramine reduces experimental pain.

Authors:  B Bromm; W Meier; E Scharein
Journal:  Pain       Date:  1986-05       Impact factor: 6.961

5.  Antagonism between tilidine and naloxone on cerebral potentials and pain ratings in man.

Authors:  B Bromm; W Meier; E Scharein
Journal:  Eur J Pharmacol       Date:  1983-03-04       Impact factor: 4.432

Review 6.  Laser-evoked cerebral potentials in the assessment of cutaneous pain sensitivity in normal subjects and patients.

Authors:  B Bromm; R D Treede
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

7.  Pentazocine and flupirtine effects on spontaneous and evoked EEG activity.

Authors:  B Bromm; R Ganzel; W M Herrmann; W Meier; E Scharein
Journal:  Neuropsychobiology       Date:  1986       Impact factor: 2.328

  7 in total
  2 in total

1.  [The infrared laser in the diagnosis of normal and disturbed pain pathways.].

Authors:  B Bromm
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

2.  [Differentiation of pain-related and morphine related impairment of cognitive performance and mood in bone marrow transplantation patients].

Authors:  J Lorenz; U Baumgärtner; A R Zander; B Bromm
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.